Patients Hospitalized With COVID-19 Infection With Abnormal Biomarkers Have Worse Outcomes, Study Finds

Infectious Disease Advisor (6/28, Chan) reported, “Patients hospitalized with COVID-19 infection with less favorable 5-day virologic and immunologic biomarker trajectories have worse prognoses, according to study results published in The Lancet Microbe.” In the study, “less favorable trajectories of low anti-nucleocapsid antibody levels, high plasma nucleocapsid antigen levels, and high inflammatory biomarkers were observed over the first 5 days of COVID-19 infection for patients with high-risk clinical characteristics at baseline.”